CDC Carestream DRX-1 to Plus CSI Detector Upgrade (35x43)
Archived on October 9, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 1:00 PM EDT
- Posted
- September 21, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- NAICS
- 339112: Surgical and Medical Instrument Manufacturing
- Agency
- Department of Health and Human ServicesOFFICE OF THE ASSISTANT SECRETARY FOR FINANCIAL RESOURCES (ASFR)
Notice details
- Office
- OMAS STRATEGIC BUYING CENTER - INFORMATION TECHNOLOGY
- Place of performance
- Bethesda, Maryland, 20892
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75D301-26-Q-79311
- Notice ID
- 76425cf3aa2840d88ef2ad6680a3f2ef
Description
This is a Notice of Intent, not a request for quotation. The Government is not requesting quotes in response to this notice.
The Department of Health and Human Services (HHS), Office of Mission Acquisition Solutions (OMAS), on behalf of the Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH), intends to award a firm-fixed-price purchase order to Carestream Health, Inc. for the Carestream DRX-1 to Plus CSI Detector Upgrade (35x43).
Period of Performance: Date of Award through 90 days after award.
The National Institute for Occupational Safety and Health (NIOSH), Coal Workers’ Health Surveillance Program (CWHSP), operates digital radiography imaging systems in support of occupational health surveillance and research activities. The existing Carestream DRX-1 detectors are aging and require replacement to maintain imaging quality, system reliability, and operational efficiency.
The purpose of this acquisition is to replace two existing Carestream DRX-1 detectors with new Carestream DRX Plus CSI detectors and ensure continued compatibility and operation with the existing Carestream digital radiography system.
The requirement includes the following:
- Carestream DRX-1 to Plus CSI New Detectors (35x43)
Quantity: Two (2) new detectors
The detectors shall be new and not refurbished.
- Installation and System Integration
The contractor shall perform onsite installation, integrate the new detectors with the existing Carestream digital radiography system, and conduct testing to verify proper operation and reliable, high-quality radiographic imaging.
- Exchange and Return of Existing Detectors
The contractor shall provide the necessary shipping materials and return labels and coordinate the return of the existing DRX-1 detectors following successful installation and testing of the new detectors.
Equipment Delivery: Within 30 days after award.
Period of Performance: Date of Award through 90 days after award.
Justification for Sole Source
The Government requires Carestream DRX Plus CSI detectors to maintain full compatibility with the existing Carestream digital radiography system currently used by the NIOSH Coal Workers’ Health Surveillance Program.
The existing digital radiography environment consists of Carestream equipment, software, hardware, and established workflow configurations. The required detectors are specifically designed to integrate with the existing Carestream DRX system. The Carestream DRX Plus CSI detectors incorporate Carestream-specific technologies, including system synchronization, wireless communication, and image-processing functionality used within the existing environment.
Use of a detector from another manufacturer would not provide the required direct compatibility with the existing Carestream system and could require replacement or modification of existing system components, development of interfaces or third-party integration, additional testing, training, and maintenance support. Introducing non-Carestream equipment would also create additional technical and operational risks and could disrupt continued radiography operations.
The Government also maintains a separate maintenance arrangement for the existing Carestream DRX system. Standardization with the existing Carestream equipment is necessary to maintain system compatibility, operational continuity, consistent imaging performance, and existing maintenance support.
The contractor must also be authorized to install and integrate Carestream DRX equipment. The requirement therefore includes not only delivery of the detectors, but installation, system integration, testing, and the exchange and return of the existing Carestream detectors.
Based on the Government’s technical requirements and market research, Carestream Health, Inc. has been identified as the only responsible source capable of satisfying the Government’s requirement without substantial duplication of cost, system incompatibility, unacceptable technical risk, or disruption to ongoing operations.
Authority
This acquisition is for commercial products and associated services and is being conducted under FAR Part 12, Acquisition of Commercial Products and Commercial Services, using the applicable simplified procedures.
In accordance with RFO FAR 12.102(a), for acquisitions valued at or below the Simplified Acquisition Threshold, the Government must document the decision that only one source is available and the basis for that decision. The basis for this proposed sole-source acquisition is that only one responsible source can satisfy the Government’s compatibility, integration, installation, and operational requirements.
The circumstances supporting this action are consistent with RFO FAR 6.103-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
Submission of Capability Statements
Interested parties that believe they are capable of satisfying the Government’s requirement may submit a capability statement electronically.
Responses will be considered solely for the purpose of determining whether the Government should conduct a competitive procurement. A determination by the Government whether to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.
Capability statements must demonstrate the ability to provide two new Carestream DRX Plus CSI detectors (35x43), including authorized onsite installation, integration with the Government’s existing Carestream digital radiography system, testing and verification of proper system operation, and coordination of the exchange and return of the Government’s existing Carestream DRX-1 detectors.
Capability statements must also demonstrate that the proposed source is authorized to provide and install the required Carestream equipment and can perform the requirement without affecting compatibility with the Government’s existing Carestream system, existing system configuration, or maintenance support.
Deadline: [INSERT DATE AND TIME] ET
Submit to:
Vera Nordalm
Contract Specialist
Office of Mission Acquisition Solutions (OMAS)
Email: vera.nordalm@hhs.gov
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
- 3Version 3Special NoticeArchivedCurrent
CDC Carestream DRX-1 to Plus CSI Detector Upgrade (35x43)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
This acquisition is for three (3) Philips Cardiac Workstation 7000 units, compatible trolleys, and implementation services for patient care at the National Institutes of Health (NIH) Clinical Center (CC) Department of Clinical Research Informatics (DCRI). • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing • Place of Performance: Bethesda, MD 20892 USA POTS: 27-000177 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Philips North America, located at 222 Jacobs St, East Cambridge, MA, on a firm fixed price sole source award basis to provide three (3) Philips Cardiac Workstation 7000 units, compatible trolleys, and implementation services for patient care at the National Institutes of Health (NIH) Clinical Center (CC) Department of Clinical Research Informatics (DCRI). The Clinical Center’s requirement is driven by interoperability with its existing EKG-to-CRIS environment. The SOW states that the Philips model can be added to the existing CRIS interfaces, enabling electronic orders/results and an automated workflow in which authorized staff can review, annotate, and sign EKG reports online for automatic upload to CRIS. The SOW further states that this automation is intended to reduce errors, keep reports digital, improve availability, and improve patient safety. A different manufacturer’s product that requires development of an additional interface would not meet the requirement as presently defined because it would add interface development, validation, implementation, and operational risk outside the intended scope. Accordingly, the unique qualification is native/established compatibility with the existing Philips-to-CRIS interface and workflow, not merely the manufacturer’s trade name. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by November 23rd, 2026 at 5pm EST. | - | Special Notice | 11/23/2026 |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Bard Peripheral Vascular Inc. Acquisition Description: Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use) for use in Interventional Radiology image-guided core needle biopsy procedures. Device is compatible with the BD TruGuide™ Disposable Coaxial Biopsy Needle and is available in 14G–20G gauges and 6–25 cm lengths to accommodate a range of lesion depths and target sites. Features include Advanced Echogenic Technology for enhanced ultrasound visibility, a Fire Ready Indicator, and a penetration depth indicator (10mm/20mm presets). Core Function: Supplies required: BD Mission™ Disposable Core Biopsy Instrument(s), single-use, sterile, for IR core needle biopsy procedures. Delivery is requested on an as-needed/recurring basis via standard vendor shipment The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000988) by 12:00 PM eastern standard time on 11/08/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | - | Pre-Solicitation | 11/08/2026 |
This acquisition is for renewal of the annual service contract for the SCIEX QTRAP 6500 mass spectrometer located in the Clinical Pharmacology Laboratory (CPL) at the National Institutes of Health (NIH). • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing • Place of Performance: Bethesda, MD 20892 USA POTS: 27-000151 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to AB Sciex LLC, located at 1201 Radio Rd, Redwood City, CA 94065, on a firm fixed price sole source award basis to provide service to the Sciex QTRAP 6500 mass spectrometer at the NIH CPL. SCIEX is the original equipment manufacturer (OEM) of the QTRAP 6500 mass spectrometer. Only SCIEX-certified engineers can service internal components, ensure firmware compatibility, and maintain the instrument’s warranty. Third-party vendors do not have access to proprietary parts, software patches, or SCIEX OS upgrades, and cannot ensure 48-hour on-site response times. SCIEX’s FlexPlan is the only service contract that: • Guarantees coverage for software, firmware, and hardware • Preserves instrument warranty • Provides regulatory-grade validation support • Ensures minimal downtime with guaranteed two-business-day response • Offers discounts on future upgrades and validation services This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by November 5, 2026 at 5pm EST. | - | Special Notice | 11/05/2026 |
See attached request for information documents. | - | Market Research | 11/18/2026 |
Request for Information 36C10X27Q0002 Department of Veterans Affairs (VA) Healthcare Technology Management (HTM) Inpatient Pharmacy Automation System (IPAS) suite and Automated unit dose repacking systems (Pill packaging system) Indefinite Delivery-Indefinite contract. THIS IS A REQUEST FOR INFORMATION (RFI) ONLY (as defined in FAR 15.101(c)), this is not a solicitation, a solicitation is not available at this time. Requests for a solicitation will not receive a response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received, provide feedback to respondents with respect to any information submitted, or respond to any questions or comments that may be submitted in response to this RFI. This notice does not constitute a commitment by the United States Government and does not obligate the Government to award a contract or otherwise pay for the information provided in response. Responders are solely responsible for all expenses associated with responding to this RFI. The purpose of this RFI is for Market Research and to gather input for use in further defining the requirement only, and to identify interested and potentially capable vendors to fulfill requirements for: 1. An Indefinite Delivery-Indefinite contract for an enterprise procurement of Automated unit dose repacking systems (Pill packaging system) for inpatient pharmacies across the country. The procurement shall include the unit dose packager, supplemental lower packaging unit, tray system, cannisters, canister calibration system, all software and interfaces required to integrated into the existing pharmacy information system. The contract shall include all software and professional services required to install and operate the inpatient medication dispensing workflow to include interfaces, licenses, equipment relocations, enterprise reporting, and Electronic Health Record integration, as well as maintenance and support agreements. It shall include VHA personnel training, technology refreshes, upgrades, additional components, architecture enhancements and licensing support as needed. 2. An Inpatient Pharmacy Automation System (IPAS) suite across the country. The suite of equipment includes automation dispensing cabinets, IV prep systems, carousels, refrigerators, auxiliary equipment and accessories. The contract shall include all software and professional services required to install and operate the inpatient medication dispensing workflow to include interfaces, licenses, equipment relocations, enterprise reporting, and Electronic Health Record integration, as well as maintenance and support agreements. It shall include VHA personnel training, technology refreshes, upgrades, additional components, architecture enhancements and licensing support as needed. The Contractor shall provide all equipment, supplies, transportation, tools, materials, supervision, and other items and non-personal services necessary to install and support the inpatient pharmacy automation system as defined in this Performance Work Statement (PWS), except for those items specified as government furnished property and services. Additionally, the Government aims to determine if this can be fulfilled under a single vehicle for executing the proposed tasks would be a viable pathway. The details of the system’s requirements and capabilities are found in: Attachment A: Draft Performance Work Statement (PWS) - Automated Unit Dose Repacking Systems (Pill packaging system) Attachment B: Draft Performance Work Statement (PWS)- Inpatient Pharmacy Automation Dispensing System 1. Background VHA Office of Healthcare Technology Management (HTM), in conjunction with Pharmacy Benefits Administration (PBM), develops and guides the comprehensive management of pharmacy technologies to assure safe, available, and innovative medical technology used to deliver exceptional health care for Veterans. HTM/Biomedical Engineering at the medical facilities direct the medical equipment management program and support clinical care through providing preventive and corrective maintenance, healthcare consulting, and professional services for the technology assessment, implementation and sustainment of medical equipment and clinical systems. Planned Performance: End of First Quarter of Fiscal Year (FY) 27. * The information provided in the RFI is subject to change and is not binding on the Government. INSTRUCTIONS FOR RESPONDING TO THIS RFI CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). Response Format/Page Limitations: In your capability statement, address how you would deliver/implement the specific tasks outlined in Attachment A and B. The overall total page limit for responses to this RFI is ten (10) pages. (Page count excludes – General Information). Responses should be submitted in Microsoft Word format with 12 pt. Vendors may also submit additional information not specifically requested above, which would provide value and insight to the Government. NO MARKETING MATERIALS ARE ALLOWED AS PART OF THIS RFI. Generic capability statements will not be accepted or reviewed. Your response must address capabilities specific to the services required in the attached draft Requirements Document. Please be advised that all submissions become Government property and will not be returned. Please provide an index to assist the Government in identifying where you have addressed each question below in your Capabilities Statement. Please provide question number corresponding page and section heading and/or paragraph number. General Information section shall include the following at a minimum: Name, mailing address, overnight delivery address (if different from mailing address), phone number, fax number, and e-mail of designated point of contact. Recommended Contract Type. Provide a recommended contract type and a justification supporting the use of a Firm-Fixed-Price (FFP) arrangement in lieu of a Labor-Hour (LH) contract. The Government’s preference is for an FFP contract; therefore, respondents are requested to explain how the requirement can be sufficiently defined, scoped, and managed to enable performance under an FFP structure. The response should describe the conditions, assumptions, and risk mitigation approaches that would support successful execution under an FFP contract. The number of pages in General Information Section shall not be included in the ten (10) page limit. The ten (10) page limit begins after the completion of General Information. Reference “36C10X27Q0002 - Automation Dispensing System and Pill Packager IDIQ” in the response and Subject Line of the email). Any organization responding to this notice should ensure that its response is complete and sufficiently detailed. Respondents are requested to limit responses to the information, and in the format provided below. Companies are encouraged to include any relevant information (specifications, cut sheets, brochures, capability statement, previous experience etc.) to confirm the company’s ability to meet the requirements outlined in this request. 2. GENERAL INFORMATION The following information is requested: Administrative Information: Company Name, mailing address, phone number, and e-mail of designated point of contact. Company Cage Code and Unique Entity Identifier (UEI). Companies must be registered in the System for Award Management (SAM, at www.sam.gov) to be considered as a potential source. Indicate the North American Industry Classification System (NAICS) code(s) under which your company typically performs Government contracts. Maximum participation by small businesses, including veteran-owned, service-disabled veteran-owned, HUBZone, small disadvantaged, and women-owned small business concerns, is encouraged. Suggested NAICS for this requirement is 339112 - Surgical and Medical Instrument Manufacturing. Identify the applicable SINs, including a description of each SIN’s product or service classification. Suggested PSC is 6515 - Medical and Surgical Instruments, Equipment, and Supplies. Small Business Designation status such as (8(a), HUBZone, Service-Disabled Veteran Owned Small Business (SDVOSB), Women-Owned, etc.). Business size status and time of last certification. The Government has not yet determined the set-aside capability. The results of this RFI will be used to assess small businesses’ capacity to fulfil this requirement and to inform the Government’s decision. Identify which pieces of equipment you offer or identify if you can supply the entire portfolio of products. Identify any contracting vehicles available to the Government for procuring this equipment and services (e.g., GSA PSS, GSA OASIS, NASA SEWP, etc.). This information is for market research purposes only and does not preclude your company from responding to this notice. Identify any products or services not manufactured in America. 3. CAPABILITY AND EXPERIENCE INFORMATION Company Qualifications: Describe your company’s capability to provide inpatient pharmacy automation systems to large, multi-facility healthcare enterprises, particularly within the Department of Veteran’s Affairs or other federal agencies. Provide examples of projects where you have successfully integrated your system with an Electronic Health Record (EHR) such as Oracle Health, MHS Genesis or other products. Please describe the hardware, software, and interface requirements to connect your systems with the EHR. Technical and System Capabilities-ADCs, Carousels, and IV prep: What are the underlying operating systems for your server and client-side equipment? Please confirm they meet the minimum requirements of Windows Server 2019 and Windows 11 or identify your plan and proposed timeline for moving to these operating systems. Does your latest system have a current Enterprise Risk Assessment (ERA)? If not, what is your plan and estimated timeline for obtaining one? Describe your system’s architecture. Is it a cloud-based, on-premises, or hybrid model? Describe the system's inherent capability to maintain data integrity and transaction continuity during degraded or disconnected network operations. What roles-based access are available to users? What functionality can the role-based access provide? Please provide the specifications of your IV prep system. Describe your system’s ability for a central pharmacy management or regional pharmacy management solutions—is it able to host individual sites to a single server located at another site—ie a single server to host 10+ facilities? 100+? Are there limitations to this set-up? Is there any cross functionality between the inpatient pharmacy automation suite and the supply automation suite? Can they leverage the same server or licenses? If yes, what options are available for supply automation suites? In the event of a power outage, what are the downtime protocols? If there is a mechanical failure, please describe if your equipment can function manually and the protocols for such. Are the packaging, labels and other consumables proprietary or are they available open market (assuming meets specifications company provides)? For your commercially available support agreement options, please provide information regarding service response times. Are parts available independent of whether a support agreement is in place? Are parts only support contracts available or the ability to schedule one-time repairs? Are there any equipment items or services that seem to be missing from the draft PWS? Are there requirements that are not applicable to the inpatient suite set up? Technical and System Capabilities-Pill packager: Provide your interface capabilities with inpatient automation vendors and identify whether this is one directional or bidirectional. What are the underlying operating systems for your server and client-side equipment? Please confirm they meet the minimum requirements of Windows Server 2019 and Windows 11 or identify your plan and proposed timeline for moving to these operating systems. Does your latest system have a current Enterprise Risk Assessment (ERA)? If not, what is your plan and estimated timeline for obtaining one? Describe your system’s architecture. Is it a cloud-based, on-premises, or hybrid model? Describe the system's inherent capability to maintain data integrity and transaction continuity during degraded or disconnected network operations. What roles-based access are available to users? What functionality can the role-based access provide? Please describe your cannister system and how new medications/new NDCs are configured? Can it be done locally or does it require sending back to the OEM? If it requires sending back to the OEM, what is the turnaround time options? What are the various sizes of cannisters and amount of cannisters available in each pill packaging unit? Are there recommendations by the vendor on which sized unit is needed where (ie if you do X, you should have at least Y size)? How many unit dose and multi-dose forms can be packaged per minute? Please describe your remote verification workflow. In the event of a power outage, what are the downtime protocols? If there is a mechanical failure, please describe if your equipment can function manually and the protocols for such. Are the packaging, labels and other consumables proprietary or are they available open market (assuming meets specifications company provides)? For your commercially available support agreement options, please provide information regarding service response times. What is the reported uptime of your system and how is it calculated? Are parts available independent of whether a support agreement is in place? Are parts only support contracts available or the ability to schedule one-time repairs? Are there any equipment items or services that seem to be missing from the draft PWS? Are there requirements that are not applicable to the inpatient pill packager? Demonstration Information: The Government requests that vendors offer a virtual demonstration on teams or another virtual meeting platform specified and approved by the government of their current operational, production ready inpatient automation dispensing cabinet suite solution pill packaging solution. The demonstration should, to the maximum extent possible, illustrate the end-to-end workflow used to support high-volume healthcare or enterprise correspondence processing. The demonstration should address the following capabilities, if available: New technologies offered in the last year Interfaces between other brands’ products Central Pharmacy Management from a single location or regional location Labeling abilities to support moderate sedation without automation Schedule for Demonstration 30-minute presentation technology and 30-minute demo with questions. Respondent must provide sides deck at least 24 hours before scheduled demonstration. Requesting demonstration between October 5 through 8, 2026, between 10:00AM-2:00PM EST. Please provide best date and time for demonstration. Email confirmation will be sent to each respondent to confirm date and time for demonstration. Interested firms are requested to provide Capability Statements addressing the following data/information requested by the closing date. In addition to providing your company’s capability statement as it pertains to the requirements of this RFI, interested and capable firms are also required to provide answers to the following questions. [ ] Yes [ ] No Does your company exceed the required number of employees/millions based on the appropriate NAICS the VA is requesting? [ ] Yes [ ] No Will at least 50 percent of the cost of performance incurred be expended for employees of your concern or employees of other eligible SDVOSB/VOSB concerns? 4.0 Responses THERE IS NO SOLICITATION AT THIS TIME. Responses to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract or agreement. This notice shall not be construed as a commitment by the Government to issue a solicitation, or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. Submission of any information in response to this market survey is purely voluntary; the Government assumes no financial responsibility for any costs incurred. Your responses may be shared with all stakeholders, thus, information received will not be considered proprietary. 4.1. Responses: RFI responses are due no later than 10:00AM September 24, 2026, ET. Responses shall be submitted to: Contracting Officer – Caitlin Ruc at Caitlin.Ruc@va.gov and Contract Specialist – Tereshia Burford at Tereshia.Burford@va.gov. 4.2. Questions: No Questions are being accepted. Depending upon the responses received, VA may request additional information, may conduct future question and answer sessions, or may conduct meetings or an industry day. 52.215-3 Request for Information or Solicitation for Planning Purposes (Oct 1997) (a) The Government does not intend to award a contract based on this RFI or to pay for the information solicited except as an allowable cost under other contracts as provided in FAR subsection 31.205-18, Independent research and development and bid and proposal costs, of the Federal Acquisition Regulation. (b) Although “proposal” and “offeror” are used in this Request for Information, your response will be treated as information only. It shall not be used as a proposal. (c) This Request is issued for the purpose of: Information Purpose Only. (End of provision) Please see Attachments: A. DRAFT Performance Work Statement (PWS) - Automated unit dose repacking systems (Pill packaging system) B. DRAFT Performance Work Statement (PWS) - Inpatient Pharmacy Automation Dispensing System See Attachments for Complete detail of request. | - | Special Notice | 09/24/2026 |
Additional Details
Solicitation Number
75D301-26-Q-79311
Archive Date
Oct 9, 2026
Office Address
Rockville, MD, 20857